Literature DB >> 2286210

Bone scan and red blood cell scan in a patient with epidermal naevus syndrome.

W Becker1, N Stosiek, K P Peters, F Wolf.   

Abstract

A bone scan and red blood cell scan in the rare epidermal naevus syndrome, associated with multiple haemangiomas of the bone and hypophosphataemic osteomalacia in a 20-year-old man are reported. The typical pattern of osteomalacia on the bone scan was associated with lesions of increased bone metabolism in the peripheral bones. The haemangiomas did not pool labelled red blood cells. Thus, the bone scan seems to be suitable for diagnosing the complete extent of haemangiomas in bone, but they could not be specifically proven by red blood cell pooling.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2286210     DOI: 10.1007/bf01268029

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  6 in total

1.  SPECT imaging of the lumbosacral spine and pelvis.

Authors:  G F Gates
Journal:  Clin Nucl Med       Date:  1988-12       Impact factor: 7.794

2.  The epidermal nevus syndrome.

Authors:  L M Solomon; D F Fretzin; R L Dewald
Journal:  Arch Dermatol       Date:  1968-03

3.  Tumorous phosphaturic osteomalacia. Report of a case associated with multiple hemangiomas of bone.

Authors:  R A Daniels; I Weisenfeld
Journal:  Am J Med       Date:  1979-07       Impact factor: 4.965

4.  Vitamin D-resistant rickets associated with epidermal nevus syndrome: demonstration of a phosphaturic substance in the dermal lesions.

Authors:  L C Aschinberg; L M Solomon; P M Zeis; P Justice; I M Rosenthal
Journal:  J Pediatr       Date:  1977-07       Impact factor: 4.406

5.  Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets.

Authors:  N Weidner; D Santa Cruz
Journal:  Cancer       Date:  1987-04-15       Impact factor: 6.860

6.  In vivo/in vitro labeling of red blood cells with 99mTc.

Authors:  R Bauer; I Haluszczynski; H Langhammer; W Bachmann
Journal:  Eur J Nucl Med       Date:  1983
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.